Formar parte de Somera
Diseñada para apoyar la formación
Consulta y aprendizaje que centraliza recursos científicos, académicos y técnicos al servicio de la comunidad médica y de salud. Contribuye al fortalecimiento del conocimiento, fomenta la actualización continua y respalda la toma de decisiones informadas.
Categoría: Externo
TNM Classification of Malignant Tumours 9th Edition
TNM Classification of Malignant Tumours 9th Edition Edited by: James Brierley, Meredith Giuliani, Brian O'Sullivan, Brian Rous, Elizabeth Van Eycken WILEY
Categoría: Socio somera
CONSENSO CANCER MAMA 2025
CONSENSO MEXICANO SOBRE DIAGNÓSTICO Y TRATAMIENTO DEL CÁNCER MAMARIO UNDÉCIMA REVISIÓN, ENERO 2025. RADIOONCOLOGÍA: Dra. Adela Poitevín Chacón Radiooncóloga Médica Sur, Ciudad de México. Dra. Christian Haydeé Flores Balcázar Radiooncóloga Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, SS., Ciudad de México.
Categoría: Socio somera
Guidelines on Prostate Cancer
EAU - EANM - ESTRO - ESUR - ISUP - SIOG Guidelines on Prostate Cancer
Categoría: Socio somera
FAST-Forward Boost
FAST-Forward Boost A randomised clinical trial testing a 1-week schedule of curative simultaneous integrated boost radiotherapy against a standard 3-week schedule in patients with early breast cancer.
Categoría: Socio somera
Neurocognitive Decline Following Radiotherapy: Mechanisms and Therapeutic Implications
Abstract: The brain undergoes ionizing radiation (IR) exposure in many clinical situations, particularly during radiotherapy for malignant brain tumors. Cranial radiation therapy is related with the hazard of long-term neurocognitive decline.
Categoría: Socio somera
Radiation-Induced Brain Injury: Age Dependency of Neurocognitive
Simple Summary: Radiation therapy-related brain damage with neurocognitive impairment is a common long-term side effect in cancer survivors and significantly impairs the quality of life. Increasing evidence indicates the increased vulnerability of the developing brain to the neurotoxic effects of ionizing radiation (IR).
Categoría: Socio somera
Radiation-Induced Cognitive Decline: Challenges and Solutions
Abstract: Radiation therapy, a common treatment for central nervous system cancers, can negatively impact cognitive function, resulting in radiation-induced cognitive decline (RICD). RICD involves a decline in cognitive abilities such as memory and attention, likely due to damage to brain white matter, inflammation, and oxidative stress
Categoría: Socio somera
Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy
As cancer survival rates continue to improve, longterm adverse effects of treatment on health and quality of life are increasingly important considerations for clinicians, patients, and familymembers. Neurocognitive deficits (NCD) are well established as a common adverse effect in brain tumor survivors, owing to the tumor itself, but also localized brain irradiation treatment.
Categoría: Socio somera
Neurocognitive Late Effects of Chemotherapy in Children
Treatment protocols for childhood cancer have changed rapidly over the years, maintaining a balance between effective therapy and acceptable toxicity.
Categoría: Socio somera
Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy
The definitive management of many pediatric malignancies requires radiation therapy (RT) to the central nervous system (CNS) that may predispose survivors to neurologic complications. A detailed understanding of radiation dosevolume effects is required to maximize the therapeutic ratio of brain irradiation.
Categoría: Externo
Guía para el manejo del dolor en pequeños procedimientos en pediatría
Guía para el manejo del dolor en pequeños procedimientos en pediatría. Dirigida a profesionales. DIRECCIÓN Y COORDINACIÓN Pilar Hilarión Subdirectora. Instituto Universitario Avedis Donabedian - Universitat Autònoma de Barcelona. Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC) Carola Orrego Subdirectora. Instituto Universitario Avedis Donabedian - Universitat Autònoma de Barcelona. Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC) Área Social de la Fundación Bancaria “la Caixa”. PERSONAS QUE HAN PARTICIPADO EN LA ELABORACIÓN DE LA GUÍA Raquel Torres Enfermera unidad del dolor Hospital Universitario La Paz de Madrid Maria del Mar Melo Enfermera unidad del dolor Hospital Universitario La Paz de Madrid Francisco Reinoso Jefe de sección de anestesia pediátrica Hospital Universitario La Paz de Madrid Encarna Gómez Enfermera Projecte Hospital Sense Dolor - Hospital Maternoinfantil Sant Joan de Déu d’Esplugues. Barcelona REVISIÓN DE LA GUÍA Esta Guía ha contado con la revisión de los profesionales de los hospitales participantes en el Programa Miremos por sus derechos con ojos de niño de la Obra Social de ”la Caixa”. • Complejo Hospitalario Universitario Insular Materno Infantil de Las Palmas de Gran Canaria • Hospital Infantil Universitario Niño Jesús de Madrid • Hospital Materno-Infantil Regional Universitario de Málaga • Hospital Maternoinfantil Sant Joan de Deu d’Esplugues. Barcelona • Hospital Universitari Vall d’Hebron de Barcelona • Hospital Universitario La Paz de Madrid • Hospital Universitario y Politécnico de La Fe de Valencia
Categoría: Socio somera
Association of Multi-Kingdom Skin Microbiota With Radiation Dermatitis in Patients
Background: The clinical significance of multi-kingdom skin microbiota in acute radiation dermatitis (ARD) is not well understood. We hypothesized that skin microbiota is associated with ARD in patients with breast cancer (BC) undergoing radiation therapy (RT) after reconstructive surgery
Categoría: Socio somera
NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation
Corresponding author: Matthew Poppe, MD; E-mail: matthew. poppe@hci.utah.edu This protocol is registered with ClinicalTrials.gov and may be viewed online at https://clinicaltrials.gov/study/NCT03345420 Author Responsible for Statistical Analysis: Kenneth Boucher, PhD. Disclosures: M.M.P. is an investor in PEEL Therapeutics, Inc., and K.E. B. serves as a consultant for Impedimed. M.M.P. also reports the following roles and associations: Vice Chair, Breast Committee, Alliance; Co-Chair, Breast Locoregional Working Group, Alliance; Member, Executive Committee and Board of Directors, Alliance; Member,
Categoría: Socio somera
Plasma Epstein-Barr Virus DNA Temporal Clearance Pattern During Induction-Concurrent (Chemo)
Purpose: Plasma Epstein−Barr virus (EBV) DNA is a widely used biomarker for nasopharyngeal carcinoma (NPC). Prior investigations predominantly assessed EBV DNA at a single time point, thus neglecting the differential prognostic implications of the temporal clearance pattern of EBV DNA during induction-concurrent (chemo)radiation therapy (RT).
Categoría: Socio somera
Stereotactic Radiation Therapy in Children and Young Adults: Can We Apply Adult Treatment Paradigms?
a Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; b Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio; c Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; d Department of Radiation Oncology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; e Department of Radiation Oncology, Stanford University, Stanford, California; and f Department of Radiation Oncology, University of California San Francisco, San Diego, California
Categoría: Socio somera
Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review
AstraZeneca. He received travel support from the Radiosurgery Society. He is member of the data safety monitoring board or advisory board for Genentech, ViewRay, AstraZeneca, and Roche. He holds leadership or fiduciary roles in the Radiosurgery Society and ASTRO. Ben J. Slotman is president of the Radiosurgery Society.
Categoría: Socio somera
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors
Summary Background In postmenopausal women with oestrogen receptor-positive early breast cancer, 5 years of adjuvant tamoxifen substantially reduces 15-year recurrence and mortality; aromatase inhibitor treatment (AIT) is even more effective. We assess the effects of further AIT among women recurrence-free after at least 5 years of endocrine therapy
Categoría: Socio somera
Emerging Role of Targeted Therapies Combined With Radiotherapy in Inoperable Stages I to III NSCLC: A Review From the IASLC ART Subcommittee.
Precision oncology has transformed the management of NSCLC by tailoring treatment to the specific genetic alterations driving oncogenesis. Targeted therapies, such as tyrosine kinase inhibitors, have been found to dramatically improve survival in patients with advanced-stage NSCLC.
Categoría: Socio somera
Irradiación cráneo-espinal pediátrica. Déficit de crecimiento y aspectos dosimétricos.
Antecedentes: La irradiación cráneo-espinal (ICE) tiene un impacto decisivo en el control de tumores pediátricos con alta probabilidad de diseminación por líquido cefalorraquídeo, pero se asocia a defectos del desarrollo de la columna vertebral en etapa de crecimiento. Objetivo: Analizar las alteraciones de columna posteriores a ICE, y la comparación dosimétrica de las técnicas de radioterapia conformada (RC) y arco volumétrico de intensidad modulada (VMAT).
Categoría: Socio somera
Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III
Introduction: Post-treatment surveillance is recommended for NSCLC owing to a high risk of recurrence, but evidence on the optimal surveillance method is lacking. This trial evaluates fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) versus contrast-enhanced CT (ceCT) for surveillance in patients with NSCLC.
